Tumors clinical trials at UCSF
1 research study open to eligible people
Tumor is when there is an abnormal growth in the body. UCSF is looking for patients with certain gene changes who have solid tumors for a clinical trial using nab-sirolimus. This trial is for adult and teen patients who want more options for their treatment.
Showing trials for
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
open to eligible people ages 12 years and up
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes
San Francisco, California and other locations
Our lead scientists for Tumors research studies include Brian Schulte, MD.